This target indicates an upside potential of over 60% from the stock's last closing price on Friday.
According to UBS, Shaily Engineering Plastics is among the few companies that hold patented technology for fixed dose and auto injector pens. The brokerage is also prepared for the launch of generic GLP1 products.
The brokerage added that it expects stronger traction and better utilisation in Shaily's consumer and industrial businesses.
It also mentioned that the company could benefit from a favourable India-US trade deal and any tariff reduction that follows.
Shaily Engineering is currently in the process of adding a large customer in consumer electronics and semiconductors.
UBS is forecasting a strong 75% compound annual growth in earnings per share for FY25 to FY28.
Currently, shares of Shaily Engineering Plastics Ltd. are trading 2.14% higher at ₹2,530.50. The stock has jumped 76% so far in 2025.
/images/ppid_59c68470-image-176396002354945608.webp)

/images/ppid_59c68470-image-17637900450557337.webp)

/images/ppid_59c68470-image-176395504095694667.webp)
/images/ppid_59c68470-image-176388253394354524.webp)
/images/ppid_a911dc6a-image-176388459733253430.webp)
/images/ppid_59c68470-image-176381755496695407.webp)
/images/ppid_59c68470-image-176387003614167599.webp)
/images/ppid_59c68470-image-176374507878393413.webp)

